Dvax yahoo finance

Key events shows relevant news articles on days with large price movements. Novavax Inc. NVAX 2.

Yahoo Finance. Sign in. Sign in to view your mail. Currency in USD. Market open.

Dvax yahoo finance

.

NWN 0. Total Cash Per Share mrq.

.

These figures prompt a critical question: Is Dynavax Technologies modestly overvalued? This article provides an in-depth valuation analysis of Dynavax Technologies, offering valuable insights for potential investors. Click here to check it out. The intrinsic value of DVAX. Dynavax Technologies Corp is a biopharmaceutical company specializing in leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are under investigation for multiple cancer indications and a vaccine for the prevention of Hepatitis B. The company's Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and adaptive immunity. The GF Value is a proprietary measure that represents the current intrinsic value of a stock. This value is derived from historical trading multiples, a GuruFocus adjustment factor based on the company's past performance and growth, and future business performance estimates.

Dvax yahoo finance

We are extremely pleased with our market share growth in the fourth quarter, which enabled us to achieve our increased product revenue guidance for the year despite the impact of expected seasonality due to increased focus on respiratory disease vaccines during the fall and winter seasons. We believe the seasonal market decline for adult hepatitis B vaccines will be limited to the fourth quarter in line with the administration of the vast majority of influenza and COVID vaccines," said Ryan Spencer, Chief Executive Officer of Dynavax. In addition to HEPLISAV-B, we continue to advance our pipeline of innovative vaccine candidates and continue to pursue strategic opportunities to accelerate our growth. The preliminary selected financial results contained herein are unaudited, subject to adjustment, and provided as an estimate in advance of the Company's announcement of complete financial results, for the three and twelve months ended December 31, Market share data are preliminary and are as of the latest market data available on December 22, Hepatitis B vaccination is universally recommended for adults aged in the U.

West ham vs arsenal timeline

Profitability Profit Margin Share Statistics Avg Vol 3 month 3 1. Effective tax rate. CRBU 0. Gross Profit ttm. The range between the high and low prices over the past day. Dividend Date 3. Cash and short-term investments. Ex-Dividend Date 4. The amount by which a company's cash balance increases or decreases in an accounting period. Avg Volume. Return on assets. Balance Sheet Total Cash mrq Key events shows relevant news articles on days with large price movements.

Wall Street expects a year-over-year decline in earnings on lower revenues when Dynavax Technologies DVAX reports results for the quarter ended September While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.

Share Statistics Avg Vol 3 month 3 1. Total assets The total amount of assets owned by a company. Listed exchange for this security. AUPH 0. Day range. Total liabilities Sum of the combined debts a company owes. Total Cash mrq. Return on Assets ttm. Net change in cash The amount by which a company's cash balance increases or decreases in an accounting period. The percent of their income that a corporation pays in taxes. Gross Profit ttm.